Novolin N (Insulin NPH): Dosing Principles, Safety, and Monitoring
What Is Novolin N?
Novolin N is an intermediate-acting human insulin (NPH – Neutral Protamine Hagedorn). Onset: 1–2 h; Peak: 4–12 h; Duration: 12–18 h. Cloudy suspension – must roll gently to mix.
Dosing Principles (General – Individualized by Clinician)
- Basal insulin: Usually once or twice daily (bedtime + morning, or dinner + bedtime).
- Starting dose: 0.1–0.2 units/kg/day (e.g., 10–20 units for 100 kg person).
- Titration: Adjust by 10–20% or 2–4 units every 3–7 days based on fasting glucose trends.
- Target fasting glucose: 80–130 mg/dL (individualized).
Critical Safety Points
- Hypoglycemia risk: Peak effect ~4–12h post-injection. Nighttime hypoglycemia common with bedtime dosing. Symptoms: tremor, sweat, hunger, confusion, seizure, coma.
- Rule of 15: If <70 mg/dL → 15g fast carb → recheck 15 min.
- Glucagon kit / Baqsimi / Gvoke: Prescribed for severe lows.
- Never share pens/vials.
- Sick day rules: Check glucose q4h, never stop insulin, hydrate, check ketones if >250 mg/dL.
Comparison
| Novolin N (NPH) | Basal Analogs (Glargine U100/U300, Degludec) | |
|---|---|---|
| Peak | Yes (4–12h) | Minimal/flat |
| Hypoglycemia risk | Higher (esp. nocturnal) | Lower |
| Cost | Lower (OTC in some states) | Higher |
| Flexibility | Fixed timing critical | Flexible timing (±3h) |
